Jerome Gangitano - InVivo Therapeutics VP Operations
| NVIVDelisted Stock | USD 1.38 0.07 5.34% |
Insider
Jerome Gangitano is VP Operations of InVivo Therapeutics Holdings
| Phone | 617 863 5500 |
| Web | https://www.invivotherapeutics.com |
InVivo Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.5371) % which means that it has lost $0.5371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9811) %, meaning that it created substantial loss on money invested by shareholders. InVivo Therapeutics' management efficiency ratios could be used to measure how well InVivo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.InVivo Therapeutics Holdings currently holds 949 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. InVivo Therapeutics has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about InVivo Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MBA CMA | SAB Biotherapeutics | 69 | |
| Angela MD | Spero Therapeutics | N/A | |
| MBA BS | CytomX Therapeutics | 45 | |
| Ramtin MD | RenovoRx | 58 | |
| KwanHong MD | Longeveron LLC | 57 | |
| AO FRACP | Assembly Biosciences | 65 | |
| MBA MD | Eliem Therapeutics | 63 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| Edward DVM | SAB Biotherapeutics | N/A | |
| Satyavrat CFA | Spero Therapeutics | 51 | |
| MHROD SHRMSCP | Assembly Biosciences | N/A | |
| Jo PalmerPhillips | Eliem Therapeutics | N/A | |
| Uri MD | Assembly Biosciences | 52 | |
| Michael Pitzner | Molecular Partners AG | N/A | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Peter Rhode | HCW Biologics | 66 | |
| Wilson Wong | Senti Biosciences | N/A | |
| Gerald Goodman | Nutriband | 76 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Jeffrey PharmD | Nutriband | 54 | |
| Lieping MD | NextCure | 67 | |
Management Performance
| Return On Equity | -0.98 | |||
| Return On Asset | -0.54 |
InVivo Therapeutics Leadership Team
Elected by the shareholders, the InVivo Therapeutics' board of directors comprises two types of representatives: InVivo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InVivo. The board's role is to monitor InVivo Therapeutics' management team and ensure that shareholders' interests are well served. InVivo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InVivo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jerome Gangitano, VP Operations | ||
| Joseph MD, CoFounder | ||
| Richard Christopher, CFO, Treasurer | ||
| Dr Langer, CoFounder Board | ||
| MD FACP, Consultant | ||
| Heather JD, Chief Counsel | ||
| Richard MD, CEO and Presidentident | ||
| Richard Toselli, Chief Medical Officer | ||
| Joseph Vacanti, CoFounder |
InVivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InVivo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.98 | |||
| Return On Asset | -0.54 | |||
| Current Valuation | (7.59 M) | |||
| Shares Outstanding | 3.11 M | |||
| Shares Owned By Insiders | 0.02 % | |||
| Shares Owned By Institutions | 3.44 % | |||
| Number Of Shares Shorted | 17.63 K | |||
| Price To Earning | (1.90) X | |||
| Price To Book | 0.1 X | |||
| EBITDA | (9.8 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |